Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,463 | 41 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $484.30 | 15 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $250.00 | 2 | $0 (2024) |
| Exelixis Inc. | $135.00 | 1 | $0 (2024) |
| Janssen Biotech, Inc. | $118.92 | 4 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $91.99 | 3 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $75.61 | 4 | $0 (2023) |
| GlaxoSmithKline, LLC. | $73.67 | 3 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $53.69 | 2 | $0 (2024) |
| Agios Pharmaceuticals, Inc. | $44.59 | 2 | $0 (2024) |
| Blueprint Medicines Corporation | $36.15 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $819.99 | 15 | Phathom Pharmaceuticals, Inc. ($250.00) |
| 2023 | $186.61 | 7 | Janssen Biotech, Inc. ($65.75) |
| 2022 | $251.67 | 8 | Gilead Sciences, Inc. ($196.69) |
| 2021 | $204.54 | 11 | Gilead Sciences, Inc. ($152.61) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Janssen Biotech, Inc. | TALVEY (Biological), TECVAYLI, DARZALEX | Food and Beverage | In-kind items and services | $30.24 | General |
| Category: Oncology | ||||||
| 12/09/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $36.15 | General |
| Category: Oncology / Rare Diseases | ||||||
| 11/06/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: Genetically Defined Disease | ||||||
| 10/23/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug), TGCT | Food and Beverage | In-kind items and services | $28.82 | General |
| Category: ONCOLOGY | ||||||
| 10/08/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), TALVEY, DARZALEX | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Oncology | ||||||
| 10/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug), Vitrakvi | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: Oncology | ||||||
| 09/24/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Genetically Defined Disease | ||||||
| 08/29/2024 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: HBV | ||||||
| 08/07/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 07/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $26.94 | General |
| Category: ONCOLOGY | ||||||
| 07/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug), Vitrakvi | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: Oncology | ||||||
| 04/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | VPRIV (Biological) | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: GENETIC DISEASE | ||||||
| 02/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2023 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/23/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: RESPIRATORY | ||||||
| 06/21/2023 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $32.93 | General |
| Category: Oncology | ||||||
| 05/17/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.77 | General |
| 05/03/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $32.82 | General |
| Category: Oncology | ||||||
| 03/16/2023 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug), Vitrakvi | Food and Beverage | In-kind items and services | $37.66 | General |
| Category: Oncology | ||||||
| 03/09/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.09 | General |
| 09/14/2022 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Oncology | ||||||
| 06/01/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 05/11/2022 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 301 | 427 | $100,113 | $32,257 |
| 2022 | 7 | 237 | 287 | $75,700 | $21,477 |
| 2021 | 6 | 262 | 299 | $91,081 | $31,391 |
| 2020 | 5 | 290 | 341 | $96,016 | $32,731 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 61 | 159 | $23,850 | $9,239 | 38.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 40 | 40 | $20,400 | $5,380 | 26.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 37 | 49 | $16,780 | $4,525 | 27.0% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 41 | 48 | $8,640 | $3,956 | 45.8% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 36 | 36 | $7,840 | $2,096 | 26.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 27 | 34 | $7,480 | $2,088 | 27.9% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 17 | 17 | $3,740 | $1,759 | 47.0% |
| 99491 | Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month | Facility | 2023 | 28 | 29 | $5,800 | $1,688 | 29.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 15 | $5,583 | $1,525 | 27.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 96 | 133 | $26,600 | $7,642 | 28.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 49 | 51 | $19,890 | $5,607 | 28.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 14 | 14 | $7,980 | $2,227 | 27.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 19 | 24 | $6,960 | $1,972 | 28.3% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 23 | 23 | $6,900 | $1,927 | 27.9% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 21 | 25 | $5,500 | $1,557 | 28.3% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 15 | 17 | $1,870 | $543.61 | 29.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 88 | 90 | $42,480 | $14,589 | 34.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 91 | 118 | $28,556 | $9,841 | 34.5% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Facility | 2021 | 35 | 39 | $7,137 | $2,467 | 34.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 20 | 20 | $6,380 | $2,218 | 34.8% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 15 | 16 | $3,824 | $1,346 | 35.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 13 | 16 | $2,704 | $930.24 | 34.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 92 | 95 | $44,840 | $15,312 | 34.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 76 | 94 | $22,748 | $7,776 | 34.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 76 | 102 | $17,238 | $5,814 | 33.7% |
About Hong Mak
Hong Mak is a Registered Nurse healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/05/2014. The National Provider Identifier (NPI) number assigned to this provider is 1437568383.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Hong Mak has received a total of $1,463 in payments from pharmaceutical and medical device companies, with $819.99 received in 2024. These payments were reported across 41 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,463).
As a Medicare-enrolled provider, Mak has provided services to 1,090 Medicare beneficiaries, totaling 1,354 services with total Medicare billing of $117,855. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Registered Nurse
- Location Brooklyn, NY
- Active Since 08/05/2014
- Last Updated 10/28/2025
- Taxonomy Code 163W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1437568383
Products in Payments
- VOQUEZNA (Drug) $250.00
- CABOMETYX (Drug) $135.00
- Vemlidy (Drug) $135.00
- Stivarga (Drug) $91.99
- SHINGRIX (Biological) $47.00
- PYRUKYND (Drug) $44.59
- AYVAKIT (Drug) $36.15
- DARZALEX (Biological) $32.93
- ERLEADA (Drug) $32.82
- TALVEY (Biological) $30.24
- Enhertu (Drug) $29.24
- QINLOCK (Drug) $28.82
- NINLARO (Drug) $26.94
- VPRIV (Biological) $26.75
- AREXVY (Drug) $26.67
- NERLYNX (Drug) $24.16
- TECVAYLI (Biological) $22.93
- LYNPARZA (Drug) $21.46
- XELJANZ (Drug) $16.67
- IMFINZI (Biological) $14.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Brooklyn
Dr. Kathleen Brooks, Nurse Practitioner, NURSE PRACTITIONER
Registered Nurse — Payments: $5,503
Alina Boshakova, Rn, RN
Registered Nurse — Payments: $3,716
Raisa Harrington, Pmhnp-Bc, PMHNP-BC
Registered Nurse — Payments: $3,665
Jacob Levy, Ms, Fnp, MS, FNP
Registered Nurse — Payments: $3,565
Ashley Wu
Registered Nurse — Payments: $3,552
Victoria Liu, Np, NP
Registered Nurse — Payments: $3,090